FXR ligands protect against hepatocellular inflammation via SOCS3 induction. [electronic resource]
Producer: 20140130Description: 1658-64 p. digitalISSN:- 1873-3913
- Animals
- Carcinoma, Hepatocellular -- drug therapy
- Cells, Cultured
- Chenodeoxycholic Acid -- pharmacology
- Hep G2 Cells
- Humans
- Inflammation -- drug therapy
- Ligands
- Lipopolysaccharides -- antagonists & inhibitors
- Liver Neoplasms -- drug therapy
- Mice
- Mice, Inbred C57BL
- Receptors, Cytoplasmic and Nuclear -- agonists
- Suppressor of Cytokine Signaling 3 Protein
- Suppressor of Cytokine Signaling Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.